FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns an agent for topical administration, having a biocidal effect, containing peptide H2N-His-Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly-COOH and auxiliary substances. Tool additionally contains peptide HN2-(CH2)10-CO-Ile-Leu-Pro-D-Phe-Lys-D-Phe-Pro-D-Phe-D-Phe-Pro-D-Phe-Arg-Arg-NH2, the ratio between peptides is from 1:2 to 2:1 (wt. % ).
EFFECT: invention provides for the treatment of vaginal herpes infection, including those complicated by bacterial infection.
3 cl, 5 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HERPES VACCINE | 2019 |
|
RU2731073C1 |
| BIOCIDAL PEPTIDE AND THE PREPARATION ON ITS BASIS | 2017 |
|
RU2678985C2 |
| HERPES VIRUS WITH A MODIFIED SPECTRUM OF TARGETS CONTAINING HYBRID GLYCOPROTEIN H | 2016 |
|
RU2732120C2 |
| BIOLOGICALLY ACTIVE PEPTIDE COMPLEXES | 2011 |
|
RU2470031C2 |
| BIOLOGICALLY ACTIVE DERIVATIVES OF ALLOFERON-1 | 2013 |
|
RU2576830C2 |
| NOVEL ISOFORM OF TRYPSIN AND USE THEREOF | 2016 |
|
RU2814729C2 |
| BIOLOGICALLY ACTIVE PEPTIDES | 2013 |
|
RU2575069C2 |
| NOVEL TRYPSIN ISOFORMS AND USE THEREOF | 2016 |
|
RU2739945C2 |
| VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION | 2017 |
|
RU2813282C2 |
| RECOMBINANT VACCINE AGAINST VARICELLA ZOSTER VIRUS (VZV) | 2020 |
|
RU2772902C1 |
